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The alkaloid uniflorine A was isolated in 2000 from the leaves of the tree Eugenia 
uniflora L, together with two other water soluble alkaloids, uniflorine B and the known alkaloid 
(+)-(3α,4α,5β)-1-methylpiperidine-3,4,5-triol piperidine.  Uniflorine A was found to be an 
inhibitor of the α-glucosidases, rat intestinal maltase and sucrase, with IC50 values of 12 and 3.1 
µM, respectively, and its structure was deduced from NMR analysis to be structure 1.  
Uniflorine B was also found to be an inhibitor of the above α-glucosidases and its structure was 
determined from NMR analysis to be structure 2. 
The initial goal of this study was to complete the total synthesis of 1 and determine the 
validity of its proposed structure.  In the event, an efficient 9-step diastereoselective synthesis of 
1 was achieved by using the Petasis borono-Mannich reaction, ring-closing metathesis and 
stereoselective cis-dihydroxylation as key steps.  The structure of our synthetic 1 was 
unequivocally established by a single-crystal X-ray crystallographic study of its pentaacetate 
derivative.  However, the 1H and 13C NMR data for synthetic 1 did not match with those 
reported for uniflorine A; the latter showed many more downfield peaks in the 1H NMR, 
perhaps consistent with the amine salt.  The 1H NMR of the hydrochloride salt of synthetic 1, 
however, did not match the literature spectroscopic data either.  We therefore concluded that the 
structure assigned to uniflorine A was not correct.  We also found that the coupling constant J1,8a 
of 4.5 Hz for uniflorine A, was more consistent with the relative syn-H-8a, H-1 configuration, 
suggesting that uniflorine A, if it was an indolizidine alkaloid, had the same H-1 configuration 
as castanospermine.  Our attempts to prepare 2-epi-1 and 1,2-di-epi-1 were unsuccessful due to 
unexpected competing side-reactions. 
In addition, the diasteresoselective synthesis of the C-1, C-2 di-epimer of 1 was 
achieved.  This synthesis employed a novel pyrrolo[1,2-c]oxazin-1-one precursor to allow for 
the reversal of π-facial diastereoselectivity in an osmium(VIII)-catalysed syn-dihydroxylation 
(DH) reaction.  The NMR spectroscopic data of this epimeric compound and that of related 
isomers did not match that of the natural product.  From a comparison of the NMR data of 
uniflorine A and uniflorine B with that of casuarine and the known synthetic 1,2,6,7-
tetrahydroxy-3-hydroxymethylpyrrolizidine isomers we concluded unequivocally that uniflorine 
B is the known alkaloid casuarine.  Although we cannot unequivocally prove the structure of 
uniflorine A, without access to the original material and data, the published data suggest that the 
natural product is also a 1,2,6,7-tetrahydroxy-3-hydroxymethylpyrrolizidine with the same 
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